Tariq Ahmad

29PUBLICATIONS
134CO-AUTHORS
Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nanotoxicology, health and safetyPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 04, 2026
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes.

|Dec 13, 2025
HLA-DQA1*05:01 and DQA1*05:05 inform choice of anti-tumor necrosis factor and concomitant use of immunomodulators in patients with inflammatory bowel disease.

Qian Zhang, Mohammed Sharip, Christopher Roberts

|Oct 13, 2025
Understanding Anti-TNF Treatment Failure: Pre-Existing Antidrug Antibodies Are Common but Do Not Neutralize Drug Activity In Vitro or Influence Clinical Response to Infliximab or Adalimumab in Patients with Crohn Disease.

Rachel Nice, Simeng Lin, Neil Chanchlani

|Jun 23, 2025
Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource.

Christopher Roberts, Jaime Peters, Aleksejs Sazonvos

|Apr 17, 2024
Defining predictors of responsiveness to advanced therapies in Crohn's disease and ulcerative colitis: protocol for the IBD-RESPONSE and nested CD-metaRESPONSE prospective, multicentre, observational cohort study in precision medicine.

Nicola J Wyatt, Hannah Watson, Carl A Anderson

|Nov 09, 2023
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib.

Zhigang Liu, James L Alexander, Kai Yee Eng

Pageof 5

Frequent Collaborators

22 joint publications

James R Goodhand

20 joint publications

Nick Kennedy

18 joint publications

Neil Chanchlani

17 joint publications

Claire M Bewshea